Publications by authors named "Fabian Zohren"

25Publications

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.

N Engl J Med 2020 06 29;382(23):2197-2206. Epub 2020 May 29.

From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois.

View Article and Find Full Text PDF
June 2020

Ataxin1L is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery.

PLoS Genet 2013 Mar 28;9(3):e1003359. Epub 2013 Mar 28.

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.

View Article and Find Full Text PDF
March 2013

The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors.

Nat Immunol 2012 Jul 8;13(8):761-9. Epub 2012 Jul 8.

Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article and Find Full Text PDF
July 2012

Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.

Arch Neurol 2011 Nov;68(11):1428-31

Department of Hematology, Oncology, and Clinical Immunology, University of Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
November 2011

Sorafenib treatment in 13 patients with acute myeloid leukemia and activating FLT3 mutations in combination with chemotherapy or as monotherapy.

Acta Haematol 2010 11;124(3):153-9. Epub 2010 Oct 11.

University of Duesseldorf, Medical Faculty, Department of Haematology, Oncology and Clinical Immunology, Duesseldorf, Germany.

View Article and Find Full Text PDF
November 2010

The role of natalizumab in hematopoietic stem cell mobilization.

Expert Opin Biol Ther 2009 Aug;9(8):1099-106

Heinrich-Heine-University, Department of Hematology, Oncology and Clinical Immunology, Duesseldorf, Germany.

View Article and Find Full Text PDF
August 2009

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans.

Blood 2008 Apr 30;111(7):3893-5. Epub 2008 Jan 30.

Department of Haematology, Oncology and Clinical Immunology, Heinrich Heine-University, Düsseldorf, Germany.

View Article and Find Full Text PDF
April 2008

Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantation.

Leuk Res 2008 Jul 25;32(7):1157-9. Epub 2008 Jan 25.

Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine University, Duesseldorf, Germany.

View Article and Find Full Text PDF
July 2008

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

Leuk Res 2007 Feb 18;31(2):257-9. Epub 2006 Apr 18.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
February 2007